Status:

UNKNOWN

Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer

Lead Sponsor:

Clinical Research Office of the Endourological Society

Conditions:

Prostate Cancer

Eligibility:

MALE

50-100 years

Phase:

PHASE2

Brief Summary

Multi-centre Randomized Clinical Trial: 106 patients with confirmed unilateral high-volume low risk (Gleason score 3 + 3) or intermediate risk prostate cancer (Gleason score 3 + 4) will undergo an IRE...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Histologically confirmed organ-confined unilateral prostate cancer with adjacent positive biopsies on transperineal template prostate biopsies or MRI targeted biopsies in combination with systematic biopsies (clinical stage T1c-T2b)
  • Gleason sum score 6 or 7
  • PSA \<15 ng/ml or PSA \> 15 ng/mL counselled with caution
  • Life expectancy of \> 10 years
  • Exclusion Criteria
  • Bleeding disorder as determined by prothrombin time (PT) \> 14.5 seconds, partial thromboplastin time (PTT) \> 34 seconds, and Platelet Count \< 140/uL
  • No ability to stop anticoagulant or anti-platelet therapy for 7 days prior the procedure.
  • Active urinary tract infection (UTI)
  • History of bladder neck contracture
  • Anaesthesia Surgical Assignment category IV or greater
  • History of inflammatory bowel disease
  • Concurrent major debilitating illness
  • Prior or concurrent malignancy except for basal cell carcinoma of the skin
  • Cardiac history including arrhythmias, ICD or pacemaker
  • Prostate calcifications greater than 5 mm.
  • Biologic or chemotherapy for prostate cancer
  • Hormonal therapy for prostate cancer within 6 months prior to procedure
  • Previous radiation to pelvis
  • Transurethral resection of the prostate / Urethral stent
  • Prior major rectal surgery (except haemorrhoids)

Exclusion

    Key Trial Info

    Start Date :

    June 1 2015

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2025

    Estimated Enrollment :

    106 Patients enrolled

    Trial Details

    Trial ID

    NCT01835977

    Start Date

    June 1 2015

    End Date

    January 1 2025

    Last Update

    December 16 2020

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.